Interim results of phase II trial of pegylated liposomal doxorubicin (PLD) followed by bexarotene in advanced cutaneous T-cell lymphoma (CTCL) Meeting Abstract


Authors: Straus, D. J.; Duvic, M.; Horwitz, S. M.; Hymes, K. B.; Goy, A.; Hernandez-Ilizaliturri, F. J.; Feldman, T.; Wegner, B.; Myskowski, P.
Abstract Title: Interim results of phase II trial of pegylated liposomal doxorubicin (PLD) followed by bexarotene in advanced cutaneous T-cell lymphoma (CTCL)
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 586s
Language: English
ACCESSION: WOS:000208852005073
DOI: 10.1200/jco.2010.28.15_suppl.8053
PROVIDER: wos
Notes: Meeting Abstract: 8053 -- Source: Wos
Altmetric Score
MSK Authors
  1. Steven M Horwitz
    364 Horwitz
  2. David J Straus
    213 Straus
  3. Patricia Myskowski
    137 Myskowski
  4. Brett C Wegner
    7 Wegner